Activin and Inhibin

hCAII-IN-8, an amide, is a highly selective carbonic anhydrase (CA) inhibitor with an IC 50 value of 0.18 μM against hCA IIIn VitrohCAII-IN-8 (compound 9: 100 μM: 24-48 h) has noncytotoxic on HEK-293 T cells (cell viability&gt:90%) compared to the

HCV-IN-30 (compound 48) is a HCV NS5A replication complex inhibitor, with IC 50 s of 901 and 102 nM for genotypes 1a and 1b replicons, respectively.Form:Solid.

HCV-IN-30 (compound 48) is a HCV NS5A replication complex inhibitor, with IC 50 s of 901 and 102 nM for genotypes 1a and 1b replicons, respectively.Form:Solid.

HCV-IN-30 (compound 48) is a HCV NS5A replication complex inhibitor, with IC 50 s of 901 and 102 nM for genotypes 1a and 1b replicons, respectively.Form:Solid.

HCV-IN-31 (compound 4) is a HCV inhibitor, with an EC 50 /EC 95 of 15.7 μM for HCV repliconForm:SolidIC50&amp: Target:EC50/EC95: 15.7 μM (HCV replicon).

HCV-IN-31 (compound 4) is a HCV inhibitor, with an EC 50 /EC 95 of 15.7 μM for HCV repliconForm:SolidIC50&amp: Target:EC50/EC95: 15.7 μM (HCV replicon).

HCV-IN-31 (compound 4) is a HCV inhibitor, with an EC 50 /EC 95 of 15.7 μM for HCV repliconForm:SolidIC50&amp: Target:EC50/EC95: 15.7 μM (HCV replicon).

HCV-IN-31 (compound 4) is a HCV inhibitor, with an EC 50 /EC 95 of 15.7 μM for HCV repliconForm:SolidIC50&amp: Target:EC50/EC95: 15.7 μM (HCV replicon).

HCV-IN-31 (compound 4) is a HCV inhibitor, with an EC 50 /EC 95 of 15.7 μM for HCV repliconForm:SolidIC50&amp: Target:EC50/EC95: 15.7 μM (HCV replicon).

HCV-IN-31 (compound 4) is a HCV inhibitor, with an EC 50 /EC 95 of 15.7 μM for HCV repliconIC50&amp: Target:EC50/EC95: 15.7 μM (HCV replicon).

HDAC-IN-4 is a selective HDAC6 and HDAC10 inhibitor with pIC 50 s of 7.2 and 6.8 in BRET assay, respectively. Antitumoral activityIn VitroHDAC-IN-4 inhibits HDAC1, HDAC2, HDAC3, HDAC8 and HDAC10 with pIC 50 s of 5.5, 4.6, 5.4, 5.4, 6.7 in FRET

HDAC-IN-4 is a selective HDAC6 and HDAC10 inhibitor with pIC 50 s of 7.2 and 6.8 in BRET assay, respectively. Antitumoral activityIn VitroHDAC-IN-4 inhibits HDAC1, HDAC2, HDAC3, HDAC8 and HDAC10 with pIC 50 s of 5.5, 4.6, 5.4, 5.4, 6.7 in FRET